Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 2/20 | 0.32 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.32 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.32 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HCAR1 | Q9BXC0 | 3/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL795718 | 0.85 | — | — | |
| SCHEMBL3553113 | 0.76 | — | — | |
| SCHEMBL4018295 | 0.74 | HCAR1 (0.34) | CYP2C9HCAR1 | |
| SCHEMBL2671246 | 0.72 | PIM1 (0.32) | — | |
| SCHEMBL2671030 | 0.72 | PIM1 (0.32) | — | |
| SCHEMBL2671245 | 0.72 | PIM1 (0.32) | — | |
| SCHEMBL285095 | 0.70 | CYP2B6 (0.47) | CYP3A4CYP2B6 | |
| SCHEMBL14723543 | 0.70 | CYP2B6 (0.47) | CYP3A4CYP2B6 | |
| SCHEMBL22939999 | 0.70 | CYP2B6 (0.47) | CYP3A4CYP2B6 | |
| SCHEMBL10647110 | 0.70 | CYP2B6 (0.47) | CYP3A4CYP2B6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8445691-B2 | Heterocyclic thiosubstituted alkanol derivatives | BAYER CROPSCIENCE AG (DE) | 2013-05-21 | — | — | US | disclosed |
| US-20120035051-A1 | Novel Heterocyclic Thiosubstituted Alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035051-A1 | Novel Heterocyclic Thiosubstituted Alkanol Derivatives | MYB, BLVRB, MYCBP | PI4KA 1029/4885PI4K2B 631/4885PI4K2A 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.